patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: PSTI Pluristem Therapeutics announces Phase 1 trial to study PLX-PAD cells at th
Share
New Message
Please login to post a reply